Related Experiment Video
Updated: Nov 29, 2025

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
Published on: March 14, 2025
Cutaneous manifestations of NAXD deficiency - A case report
Mohammad Umair Malik1, Haleema Nadir1,2, Zita Maria Jessop1,3
1The Welsh Centre for Burns and Plastic Surgery, Morriston Hospital, Heol Maes Eglwys, Morriston, Cwmrhydyceirw, Swansea, SA6 6NL, United Kingdom.
Abstract:
Metabolism is a tightly regulated sequence of events, supported by key reactions between enzymes and enzyme-specific substrates. These reactions have the potential to produce metabolic side products that can have deleterious effects to further key metabolic reactions. The nicotinamide repair system consists of two partner enzymes, NAD(P)HX epimerase (NAXE) and NAD(P)HX dehydratase (NAXD). These enzymes regulate the levels of metabolic side products. Here we present a case of an 11-month old child who presented to our paediatric department with pyrexia, lethargy and multiple cutaneous lesions on the background of NAXD deficiency, a lethal neurometabolic disorder of early childhood. Despite early intervention with intravenous antibiotics, the patient failed to improve and subsequently passed away. The skin lesions were thought to be a consequence of systemic disease rather than a propagator of infection. Clinicians should be aware of this incredibly rare metabolic disease, its potential to cause widespread systemic dysfunction and the developing avenues for management.
Insights
NAD(P)HX dehydratase (NAXD) deficiency, a rare lethal neurometabolic disorder, can cause severe systemic dysfunction in infants. This case highlights the critical need for early recognition and awareness of this condition among clinicians.
Area of Science:
- Biochemistry
- Metabolic Disorders
- Enzymology
Background:
- Metabolism involves regulated enzymatic reactions producing essential products and potentially harmful side products.
- The nicotinamide repair system, including NAD(P)HX epimerase (NAXE) and NAD(P)HX dehydratase (NAXD), manages these metabolic byproducts.
- Dysregulation of this system can lead to severe health consequences.
Observation:
- An 11-month-old infant presented with pyrexia, lethargy, and widespread cutaneous lesions.
- The infant had a confirmed deficiency in NAD(P)HX dehydratase (NAXD).
- Despite antibiotic treatment, the patient's condition deteriorated.
Findings:
- NAD(P)HX dehydratase (NAXD) deficiency is a lethal neurometabolic disorder.
- The observed systemic dysfunction and cutaneous lesions were attributed to the underlying metabolic defect.
- The patient's rapid decline underscored the severity of the condition.
Implications:
- Clinicians must be aware of NAXD deficiency as a rare but critical cause of infant morbidity.
- Early diagnosis and potential therapeutic strategies for NAXD deficiency require further investigation.
- Understanding the systemic impact of metabolic disorders is crucial for effective patient management.
Related Concept Videos
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Endocarditis II: Clinical Features of Infective Endocarditis
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Nephrotic Syndrome I : Introduction
Chronic Kidney Disease II: Clinical Manifestations

